BioAdvance News

Preclinical oncology biotech Immunome files for a $30 million IPO

By WebmasterSeptember 9, 2020November 1st, 2024No Comments

Preclinical oncology biotech Immunome files for a $30 million IPO

Previous PostWellsheet Deployed by RWJBarnabas Health Improves Clinical Workflow and Improves Patient Care
Next PostAnnovis Bio Begins Treatment of First Patients in its Phase 2a Alzheimer’s and Parkinson’s Trial